{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:32:59Z","timestamp":1795026779311,"version":"4.10.2"},"reference-count":28,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009128","name":"Research for Patient Benefit Programme","doi-asserted-by":"publisher","award":["PB-PG-1013-32076"],"award-info":[{"award-number":["PB-PG-1013-32076"]}],"id":[{"id":"10.13039\/501100009128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2023,9,8]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Catheter-related sepsis (CRS) is a major complication with significant morbidity and mortality. Evidence is lacking regarding the most appropriate antiseptic for skin disinfection before percutaneous central venous catheter (PCVC) insertion in preterm neonates. To inform the feasibility and design of a definitive randomised controlled trial (RCT) of two antiseptic formulations, we conducted the Antiseptic Randomised Controlled Trial for Insertion of Catheters (ARCTIC) feasibility study to assess catheter colonisation, sepsis, and skin morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Feasibility RCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Two UK tertiary-level neonatal intensive care units.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Preterm infants born &lt;34 weeks\u2019 gestation scheduled to undergo PCVC insertion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Skin disinfection with either 2% chlorhexidine gluconate (CHG)-aqueous or 2% CHG-70% isopropyl alcohol (IPA) before PCVC insertion and at removal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome<\/jats:title>\n                    <jats:p>Proportion in the 2% CHG-70% IPA arm with a colonised catheter at removal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main feasibility outcomes<\/jats:title>\n                    <jats:p>Rates of: (1) CRS, catheter-associated sepsis (CAS), and CRS\/CAS per 1,000 PCVC days; (2) recruitment and retention; (3) data completeness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Safety outcomes<\/jats:title>\n                    <jats:p>Daily skin morbidity scores recorded from catheter insertion until 48\u2009hours post-removal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>116 babies were randomised. Primary outcome incidence was 4.1% (95% confidence interval: 0.9% to 11.5%). Overall catheter colonisation rate was 5.2% (5\/97); CRS 2.3\/1000 catheter days; CAS 14.8\/1000 catheter days. Recruitment, retention and data completeness were good. No major antiseptic-related skin injury was reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A definitive comparative efficacy trial is feasible, but the very low catheter colonisation rate would make a large-scale RCT challenging due to the very large sample size required. ARCTIC provides preliminary reassurance supporting potential safe use of 2% CHG-70% IPA and 2% CHG-aqueous in preterm neonates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN82571474\">ISRCTN82571474<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2023-325871","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:58:02Z","timestamp":1698760682000},"page":"202-210","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial"],"prefix":"10.1136","volume":"109","clinical-trial-number":[{"clinical-trial-number":"isrctn82571474","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6203-7632","authenticated-orcid":false,"given":"Paul","family":"Clarke","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1820-8718","authenticated-orcid":false,"given":"Aung","family":"Soe","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Medway Maritime Hospital, Gillingham, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-2588","authenticated-orcid":false,"given":"Amy","family":"Nichols","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1483-4770","authenticated-orcid":false,"given":"Helen","family":"Harizaj","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Medway Maritime Hospital, Gillingham, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9169-7592","authenticated-orcid":false,"given":"Mark A","family":"Webber","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK"},{"name":"Quadram Institute Bioscience, Norwich, Norfolk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-6511","authenticated-orcid":false,"given":"Louise","family":"Linsell","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-0715","authenticated-orcid":false,"given":"Jennifer L","family":"Bell","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6411-669X","authenticated-orcid":false,"given":"Catherine","family":"Tremlett","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9784-8918","authenticated-orcid":false,"given":"Priyadarsini","family":"Muthukumar","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3495-450X","authenticated-orcid":false,"given":"Santosh","family":"Pattnayak","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Medway Maritime Hospital, Gillingham, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5139-3412","authenticated-orcid":false,"given":"Christopher","family":"Partlett","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-2718","authenticated-orcid":false,"given":"Andrew","family":"King","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-2247","authenticated-orcid":false,"given":"Ed","family":"Juszczak","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-7433","authenticated-orcid":false,"given":"Paul T","family":"Heath","sequence":"additional","affiliation":[{"name":"Centre for Neonatal and Paediatric Infection, Infection and Immunity, Saint George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"2025090512380565000_109.2.202.1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-300822"},{"key":"2025090512380565000_109.2.202.2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/apa.12779","article-title":"Skin colonisation at the catheter exit site is strongly associated with catheter colonisation and catheter-related sepsis","volume":"103","author":"Ponnusamy","year":"2014","journal-title":"Acta Paediatr"},{"key":"2025090512380565000_109.2.202.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028022","article-title":"Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol","volume":"9","author":"Clarke","year":"2019","journal-title":"BMJ Open"},{"key":"2025090512380565000_109.2.202.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.19.2357"},{"key":"2025090512380565000_109.2.202.5","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2011.40"},{"key":"2025090512380565000_109.2.202.6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007407","article-title":"Devastating coagulase-negative staphylococcal septicaemia in an extremely low birth weight infant","volume":"2012","author":"Samarasekara","year":"2012","journal-title":"BMJ Case Rep"},{"key":"2025090512380565000_109.2.202.7","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-316004"},{"key":"2025090512380565000_109.2.202.8","unstructured":"Department of Health . Saving Lives: reducing infection, delivering clean and safe care. High Impact Intervention No 1. Central venous catheter care bundle. 2007. Available: http:\/\/webarchive.nationalarchives.gov.uk\/20120118164404\/hcai.dh.gov.uk\/files\/2011\/03\/2011-03-14-HII-Central-Venous-Catheter-Care-Bundle-FINAL.pdf"},{"key":"2025090512380565000_109.2.202.9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.semperi.2017.03.006","article-title":"Central line-associated bloodstream infections in the NICU: successes and controversies in the quest for zero","volume":"41","author":"Mobley","year":"2017","journal-title":"Semin Perinatol"},{"key":"2025090512380565000_109.2.202.10","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313362"},{"key":"2025090512380565000_109.2.202.11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2523"},{"key":"2025090512380565000_109.2.202.12","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313150"},{"key":"2025090512380565000_109.2.202.13","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000064"},{"key":"2025090512380565000_109.2.202.14","doi-asserted-by":"publisher","DOI":"10.1097\/00129804-200207000-00007"},{"key":"2025090512380565000_109.2.202.15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-11-200206040-00007"},{"key":"2025090512380565000_109.2.202.16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0195-6701(07)60002-4","article-title":"Epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England","volume":"65 Suppl 1","author":"Pratt","year":"2007","journal-title":"J Hosp Infect"},{"key":"2025090512380565000_109.2.202.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-6701(13)60012-2"},{"key":"2025090512380565000_109.2.202.18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jpeds.2017.08.002","article-title":"Chlorhexidine-induced chemical burns in very low birth weight infants","volume":"191","author":"Neri","year":"2017","journal-title":"J Pediatr"},{"key":"2025090512380565000_109.2.202.19","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304378"},{"key":"2025090512380565000_109.2.202.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204894","article-title":"Variation in infection prevention practices for peripherally inserted central venous catheters: A survey of neonatal units in England and Wales","volume":"13","author":"Fraser","year":"2018","journal-title":"PLoS One"},{"key":"2025090512380565000_109.2.202.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197706092962301"},{"key":"2025090512380565000_109.2.202.22","doi-asserted-by":"publisher","DOI":"10.1177\/0884217504265174"},{"key":"2025090512380565000_109.2.202.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2025090512380565000_109.2.202.24","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-312193"},{"key":"2025090512380565000_109.2.202.25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41372-022-01337-1","article-title":"2% aqueous vs alcohol-based chlorhexidine for skin antisepsis in VLBW neonates undergoing peripheral venipuncture: a non-inferiority trial","volume":"42","author":"Jain","year":"2022","journal-title":"J Perinatol"},{"key":"2025090512380565000_109.2.202.26","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-321174"},{"key":"2025090512380565000_109.2.202.27","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-312694"},{"key":"2025090512380565000_109.2.202.28","doi-asserted-by":"publisher","DOI":"10.1053\/jhin.2002.1249"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-325871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:38:13Z","timestamp":1757101093000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-325871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,19]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/archdischild-2023-325871"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-325871","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}